Back to HomeBeta

ICD-10 Coding for Connective Tissue Disorder(M35.9, M35.1)

Complete ICD-10-CM coding and documentation guide for Connective Tissue Disorder. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Autoimmune Connective Tissue DisorderMixed Connective Tissue Disease

Related ICD-10 Code Ranges

Complete code families applicable to Connective Tissue Disorder

M30-M36Primary Range

Systemic connective tissue disorders

This range includes all systemic connective tissue disorders, which are the primary focus for coding and documentation.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
M35.9Systemic involvement of connective tissue, unspecifiedUse when the specific type of connective tissue disorder is not documented.
  • General symptoms of connective tissue involvement without specific serologic or clinical criteria
M35.1Mixed connective tissue diseaseUse when there is serologic evidence of anti-U1 RNP antibodies and clinical overlap features.
  • Positive anti-U1 RNP antibody
  • Clinical overlap features such as Raynaud’s phenomenon, synovitis

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for connective tissue disorder

Essential facts and insights about Connective Tissue Disorder

The ICD-10 code for an unspecified connective tissue disorder is M35.9. For mixed connective tissue disease, use M35.1.

Primary ICD-10-CM Codes for connective tissue disorder

Systemic involvement of connective tissue, unspecified
Billable Code

Decision Criteria

clinical Criteria

  • Lack of specific serologic markers or clinical criteria for a more specific diagnosis.

Applicable To

  • Autoimmune connective tissue disorder NOS

Excludes

  • Specific connective tissue diseases like SLE, scleroderma

Clinical Validation Requirements

  • General symptoms of connective tissue involvement without specific serologic or clinical criteria

Code-Specific Risks

  • Risk of under-coding if specific serologic or clinical criteria are present but not documented.

Coding Notes

  • Ensure documentation supports the use of unspecified codes by confirming the absence of specific diagnostic criteria.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Pulmonary hypertension secondary to connective tissue disease

I27.0
Use when pulmonary hypertension is a complication of the connective tissue disorder.

Interstitial lung disease, unspecified

J84.9
Use when lung involvement is present.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Mixed connective tissue disease

M35.1
Presence of anti-U1 RNP antibodies and clinical overlap features.

Systemic lupus erythematosus, unspecified

M32.9
Differentiate based on specific serologic markers like anti-dsDNA.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Connective Tissue Disorder to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code M35.9.

Impact

Clinical: May lead to incorrect diagnosis and treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims and reduced reimbursement.

Mitigation Strategy

Ensure lab results are included in the patient record., Educate providers on documentation standards.

Impact

Reimbursement: May result in lower reimbursement if specific codes are not used., Compliance: Non-compliance with coding guidelines for specificity., Data Quality: Decreases accuracy of clinical data.

Mitigation Strategy

Query the provider to confirm specific antibodies and clinical features.

Impact

Risk of audits due to use of unspecified codes when specific criteria are present.

Mitigation Strategy

Implement regular training for providers on documentation requirements.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Connective Tissue Disorder, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Connective Tissue Disorder

Use these documentation templates to ensure complete and accurate documentation for Connective Tissue Disorder. These templates include all required elements for proper coding and billing.

Documenting Mixed Connective Tissue Disease

Specialty: Rheumatology

Required Elements

  • Clinical symptoms
  • Serologic test results
  • Imaging findings
  • Treatment plan

Example Documentation

Patient presents with Raynaud’s phenomenon, synovitis, and positive anti-U1 RNP antibody. Plan includes monitoring and treatment with immunosuppressants.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has joint pain and fatigue.
Good Documentation Example
Patient presents with symmetric polyarthritis, Raynaud’s phenomenon, and positive anti-U1 RNP antibody.
Explanation
The good example provides specific clinical and serologic details necessary for accurate coding.

Need help with ICD-10 coding for Connective Tissue Disorder? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more